Virological significance of HBeAg subtypes (HBeAg/1 and HBeAg/2) in patients with type B hepatitis
- 1 January 1987
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 7 (1) , 15-19
- https://doi.org/10.1002/hep.1840070105
Abstract
In order to establish the virological significance of HBeAg subtypes (HBeAg/1 and HBeAg/2) during hepatitis B virus infection, HBsAg, HBeAg and hepatitis B virus DNA in serum and HBeAg in liver were determined quantitatively in relation to the detection of HBeAg subtypes in agar gel diffusion. Thirty-eight chronic HBsAg carriers with HBeAg, including 16 non-specific reactive hepatitis, 8 chronic persistent hepatitis, 11 chronic active hepatitis and 3 liver cirrhosis, who were seen at Tohoku University Hospital from 1983 to 1985, were examined. Significantly larger amounts of HBsAg, HBeAg and hepatitis B virus DNA in serum and HBeAg in liver were found in patients positive for both HBeAg/1 and HBeAg/2 in serum than in those positive for only HBeAg/1 or negative for both subtypes. These results suggest that the presence of HBeAg/2 in serum may reflect the occurrence of active viral replication. When the detection pattern of HBeAg subtypes was examined during serial follow-up for at least 1 year, three groups of patients were classified with respect to the presence of HBeAg/2, i.e., Type I, consistently positive for HBeAg/2, Type II, consistently negative for HBeAg/2, and Type III, intermittently positive for HBeAg/2. More than 80% of Type I patients were histologically diagnosed having as nonspecific reactive hepatitis, while more than 80% of Type II and III patients had more progressive liver diseases such as chronic persistent hepatitis, chronic active hepatitis and liver cirrhosis. These results suggest that the serial examination of HBeAg subtypes in serum may be important for more detailed evaluations of type B hepatitis.This publication has 24 references indexed in Scilit:
- Prognostic value of hepatitis B core antigen (HBcAg) expression in the liver of children with chronic hepatitis type BLiver International, 1985
- Factors Influencing Postexposure Immunprophylaxis of Hepatitis B Virus Infection With Hepatitis B Immune GlobulinGastroenterology, 1985
- The Use of Antiavidin Antibody and Avidin-Biotin-Peroxidase Complex in Immunoperoxidase TechnicsAmerican Journal of Clinical Pathology, 1981
- The HBe antigen-antibody system and its relationship to clinical and laboratory findings in 100 chronic HBsAg carriers in great britainJournal of Medical Virology, 1981
- Antigenic Conversion from HBeAg to HBeAg by Degradation of Hepatitis B Core ParticlesIntervirology, 1979
- Demonstration of Hepatitis B e Antigen (HBeAg) in Association with Intact Dane ParticlesJournal of General Virology, 1979
- Hepatitis B e Antigen and Infectivity of Hepatitis B VirusThe Journal of Infectious Diseases, 1977
- BEHAVIOUR OF e ANTIGEN AND ANTIBODY DURING CHRONIC ACTIVE LIVER DISEASE RELATION TO HB ANTIGEN-ANTIBODY SYSTEM AND PROGNOSISThe Lancet, 1976
- E Antigen and Anti-E in the Serum of Asymptomatic Carrier Mothers as Indicators of Positive and Negative Transmission of Hepatitis B Virus to Their InfantsNew England Journal of Medicine, 1976
- Dane Particles, DNA Polymerase, and e-Antigen in Two Different Categories of Hepatitis B Antigen CarriersIntervirology, 1975